Periodic unilateral eyelid retraction in a pediatric patient

Nandini G Gandhi1, Gina M Rogers, Randy H Kardon

  • 1Department of Ophthalmology and Visual Sciences, University of Iowa Hospitals and Clinics, Iowa City, Iowa, USA. nandini.gandhi@gmail.com

Insights

A unique case of periodic eyelid spasms during anesthesia in a child with congenital eyelid retraction is presented. Surgical correction improved the eyelid malposition, with no recurrence postoperatively.

Area of Science:

  • Ophthalmology
  • Neurology
  • Anesthesiology

Background:

  • Congenital eyelid retraction is a common condition affecting eyelid position.
  • Cyclic oculomotor palsy is a rare neurological disorder characterized by periodic eye movement abnormalities.

Observation:

  • An 11-year-old girl with congenital right upper eyelid retraction developed periodic, cyclic spasms of the affected eyelid during general anesthesia.
  • These spasms occurred precisely every 48 seconds, causing rapid eyelid elevation without affecting pupil size or eye position.
  • The contralateral eyelid remained unaffected, and no underlying neurological or thyroid abnormalities were identified.

Findings:

  • The patient underwent successful levator recession surgery for the eyelid malposition.
  • Postoperative evaluation revealed no recurrence of cyclic eyelid spasms or other oculomotor abnormalities in the waking state.
  • This case highlights an unusual presentation of congenital eyelid retraction with intraoperative cyclic spasms, distinct from typical cyclic oculomotor palsy.

Implications:

  • This unique case expands the spectrum of congenital eyelid retraction presentations.
  • It suggests potential anesthetic-induced neurological phenomena that can mimic or coexist with pre-existing conditions.
  • Further investigation may be warranted to understand the mechanisms underlying such intraoperative cyclic eyelid spasms.

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
326
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
305
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
242
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
274